Natural Grocers (NGVC) Form 144 Filed for 2,000-Share Sale

Rhea-AI Filing Summary

Natural Grocers by Vitamin Cottage, Inc. (NGVC) filed a Form 144 to report a proposed sale of 2,000 shares of Common Stock through Apex Clearing on the NYSE with an aggregate market value of $77,620.00 and approximately 22,954,109 shares outstanding. The shares were originally acquired on 07/30/2012 as an issuer stock grant totaling 49,365 shares. The filer also reported a prior sale of 2,000 shares on 06/11/2025 that generated gross proceeds of $88,520.00. The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.

Positive

• Compliance disclosure completed under Rule 144, providing transparency about a proposed sale
• Origin of shares documented (issuer stock grant dated 07/30/2012), aiding traceability

Negative

• Recent prior sale reported (2,000 shares sold on 06/11/2025 for $88,520.00), indicating ongoing disposition of shares

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for a small block of shares from a longstanding stock grant; no new financial data disclosed.

The filing documents a proposed sale of 2,000 NGVC shares acquired in 2012 as an issuer stock grant. The use of Apex Clearing and NYSE execution is noted, and the form contains the required representation regarding undisclosed material information. This is a compliance-driven disclosure rather than an operational or financial update; it informs market participants of potential share supply but does not provide new company performance metrics.

Corporate Governance Specialist

TL;DR: Disclosure aligns with Rule 144 requirements and indicates prior recent sales by the same account.

The Form 144 identifies the origin of the shares as a 2012 issuer grant and records a prior sale by the same person on 06/11/2025. From a governance perspective, the filing demonstrates adherence to reporting obligations for insider/affiliate sales. It contains the standard signature attestation about material information and cautions regarding trading-plan representations, meeting regulatory formalities.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	APEX CLEARING 350 N ST. PAUL ST SUITE 300 DALLAS TX 75201	2000	77620.00	22954109	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/30/2012	Issuer Stock Grant	Natural Grocers by Vitamin Cottage, Inc.			49365	07/30/2012	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lark Isely 26 Lewis Peak Road Waitsburg WA 99361	Common Stock	06/11/2025	2000	88520.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by NGVC report?

The Form 144 reports a proposed sale of 2,000 shares of Common Stock via Apex Clearing on the NYSE with an aggregate market value of $77,620.00.

When were the shares being sold originally acquired?

The shares were acquired on 07/30/2012 as an issuer stock grant totaling 49,365 shares.

Has the filer sold any NGVC shares recently?

Yes. The filer reported a sale of 2,000 shares on 06/11/2025 with gross proceeds of $88,520.00.

Through which broker and exchange is the proposed sale to occur?

The proposed sale lists Apex Clearing as the broker and the NYSE as the exchange.

Does the filing state whether the seller has undisclosed material information?

The notice includes the standard representation that the seller does not know any material adverse information about the issuer that has not been publicly disclosed.